News

WuXi Biologics Ireland: Delivering Measurable Sustainability Progress Through Purposeful Innovation
From renewable energy and workforce diversity to local partnerships and sustainable technology, WuXi Biologics' Dundalk site is redefining responsible growth in biomanufacturing. DUNDALK ...
NTT DATA Expands Global Data Center Footprint with Land Acquisitions Across Seven Strategic Markets
Strategic expansion will bring nearly a gigawatt of future data center capacity in key regions around the globe NTT DATA, a global digital business and technology services leader, today announced ...
Palo Alto Networks: Cybersicherheit als sicherer Hafen in unsicheren Zeiten!
Wie geht es nach dem Breakout weiter? Rückblick Palo Alto Networks als eines der weltweit größten Cybersicherheitsunternehmen ...
Broadwind, Inc.: Broadwind Announces First Quarter 2025 Results
Broadwind (Nasdaq: BWEN, or the "Company"), a diversified precision manufacturer of specialized components and solutions serving global markets, today ...
Honda Motor Co., Ltd. (HMC:NYSE) announced its consolidated financial results for the fiscal year ended March 31, 2025
TOKYO, May 13, 2025 /PRNewswire/ -- Honda Motor Co., Ltd. today announced its consolidated financial results for the fiscal year ended March 31, 2025. Financial ...
Türkiye Sise ve Cam Fabrikalari: Sisecam's net sales amounted to 45 billion TRY in the first three months of the year
Sisecam announced financial results for the first three months of 2025. In the three-month period, Sisecam's consolidated net sales totaled TRY 45 billion.
Silicon Labs Reports First Quarter 2025 Results
Wireless IoT leader delivers strong sequential and year-over-year revenue growth AUSTIN, Texas, May 13, 2025 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power ...
Leap Therapeutics, Inc.: Leap Therapeutics Reports First Quarter 2025 Financial Results
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology ...
Minerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
BURLINGTON, Mass., May 13, 2025(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business upd ...
Börsenplatz Zürich: Adecco - mit KI und Flexibilität in die Zukunft
Die Geschäfte könnten bei Adecco besser laufen. Im ersten Quartal 2025 ging der Umsatz zurück. Sorgenkind ist die Technologieberater-Sparte Akkodis. Für die Zukunft sieht sich Adecco trotzdem gut aufg ...
CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
Company advancing plans to develop TPI 287, a novel, late stage abeotaxane that appears to cross the blood-brain barrier and has published clinical efficacy data in glioblastoma multiforme (GBM)Manage ...
BK Technologies Corporation: BK Technologies Announces First Quarter 2025 Results
Revenue growth to $19.1 million; Achieves gross margin of 47.0%1Q25 GAAP diluted EPS of $0.55 compared with $0.19 in 1Q241Q25 non-GAAP diluted adjusted EPS1 of $0.68 compared with $0.30 in 1Q24Reitera ...